Listeria Susceptibility in Patients With Multiple Myeloma Receiving Daratumumab-Based Therapy
2019
This case-control study examines the association of Listeria monocytogenes susceptibility with the receipt of daratumamab-based therapy in Canadian patients with multiple myeloma.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
6
References
5
Citations
NaN
KQI